The Global cancer diagnostics market is expected to grow at considerably high in the forecoming year. Major factors driving growth of the global cancer diagnostics market is increasing in tobacco use including cigarettes and smokeless tobacco which is a leading cause of cancer, is expected to boost the cancer diagnostic market. In addition, unhealthy diet with low fruit and vegetable intake, lack of physical activity, increasing incidence sexually transmitted HPV-infection, rising exposure of ultraviolet radiation, urban air pollution are the factors fueling growth of the global cancer diagnostic market

The global cancer diagnostics market report has been segmented on the basis method, application and region

On the basis of method, the global cancer diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), enzyme-linked fluourescent assay (ELFA), polymerase chain reaction (PCR), next generation sequencing (NGS), immunohistochemistry, microarray, imaging, biopsy, and others (barium enema, serological method etc.)

The imaging segment is projected to account for major share in terms of revenue in the global cancer diagnostics market during the forecast period. The Imaging segment includes various methods such as magnetic resonance imaging (MRI), computed tomography (CT scan), positron emission tomography (PET), ultrasound, and mammography which along with other laboratory and genetic tests to determine the location and severity of the condition in diagnosing a variety of cancer type.

On the basis of application, the global cancer diagnostics market has been segmented into breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, liver cancer, pancreatic cancer, ovarian cancer, and other (esophageal cancer, brain cancer etc.). The breast cancer application is estimated to account for significant market share in the global cancer diagnostic market in terms of revenue.

Request for the Sample Report Here: https://marketresearch.biz/report/cancer-diagnostics-market/request-sample/

On the basis of region, the global cancer diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America cancer diagnostics market is expected to account for major share in terms of revenue in 2017, and is expected to maintain its dominance over the forecast period, owing to high incidence rate of cancer among the population in the countries of this region. However, Asia Pacific cancer diagnostics market is projected to register highest CAGR in the next five years.

Key players operating in the global cancer diagnostics market include, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Agilent Technologies, Inc., Roche Diagnostics GmbH, QIAGEN N.V., Illumina, Inc., Eli Lilly and Co., and Philips Healthcare Informatics, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: